KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.
KACTUS: CAR-T Target Antigens

KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.
At KACTUS, they offer a comprehensive range of high-quality recombinant HLA-G and LILR proteins, to support research and development in immunology and therapeutic applications.
KACTUS have developed a series of immune checkpoint proteins with various tags.
KACTUS provides a variety of highly active CD3 proteins, including monomers, dimers, and other forms, to meet the diverse needs of researchers.
KACTUS’ high-quality CD19 proteins are designed for applications such as antibody screening, CAR-T cell therapy development and affinity measurements.
In order to provide the most biologically active proteins, many of Leinco Technologies’ proteins are expressed using mammalian host cells,
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.
Originally published on Forbes –
Thinking Outside The Tank: Why This Startup Thinks Fruit Flies Will Solve Synbio’s Scale-Up Problem
Future Fields is focussed on scaling biomanufacturing.
AdipoGen Life Sciences specialises in the development of recombinant proteins that show enhanced activity and stability, produced in mammalian cells.